查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1926918

非接觸式生命徵象檢測器市場：按技術、組件、應用和最終用戶分類 - 全球預測（2026-2032 年）

Non-contact Vital Signs Detector Market by Technology, Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年非接觸式生命徵象檢測器市值為 3.388 億美元，預計到 2026 年將成長至 3.6883 億美元，到 2032 年預計將達到 6.6758 億美元，複合年成長率為 10.17%。

關鍵市場統計數據
基準年 2025 3.388億美元
預計年份：2026年 3.6883億美元
預測年份 2032 6.6758億美元
複合年成長率 (%) 10.17%

這本權威入門讀物說明了非接觸式生命徵象檢測技術的基本原理、相關人員的期望和監管因素，並涵蓋了臨床和消費者領域的技術趨勢。

非接觸式生命徵象偵測技術已從一個小眾研究領域發展成為醫療保健、家用電子電器、汽車安全和國防等領域交叉融合的多維前沿技術。感測器精度、訊號處理和機器學習的最新進展使得無需直接接觸皮膚即可採集心率、呼吸頻率和運動相關生物標記物，從而為臨床和非臨床環境下的連續監測開闢了新途徑。隨著該技術的應用範圍不斷擴大，相關人員面臨著臨床檢驗要求、監管路徑和隱私考慮等諸多複雜因素的相互作用，這些因素將決定這些系統從試點部署到家庭、醫院和公共場所常規使用的速度。

模態融合、邊緣人工智慧成熟度和監管政策的明朗化正在重塑非接觸式健康監測的產品藍圖和臨床應用路徑。

非接觸式生命徵象檢測領域正經歷變革性的轉折點，主要得益於技術融合、法規演變和使用者期望的改變。雷達、熱成像、聲學感測和影像分析等核心感測器技術不再孤立存在，開發人員通常會將多種測量技術融合起來，以彌補各自的局限性，並在實際環境中實現高精度輸出。同時，邊緣運算和最佳化的數位訊號處理技術能夠實現低延遲推理，並降低對雲端連接的依賴，從而增強隱私保護，並支援在頻寬受限的環境中部署。

評估2025年關稅調整如何影響非接觸式生命徵象系統的供應鏈韌性、模組化設計應用與籌資策略。

2025年實施的關稅政策為支持非接觸式生命徵象檢測系統的全球供應鏈帶來了顯著的複雜性。雷達模組、熱感成像器、相機模組以及某些類型的半導體等組件通常從國際供應商採購，進口關稅的變化將對到岸成本、組件籌資策略和供應商關係產生重大影響。為此，製造商和系統整合商正在採取各種戰術性和戰略措施來降低風險，包括將關鍵組裝流程遷回國內、簽訂長期供應協議以及在不同司法管轄區尋找替代供應商。

有針對性的細分分析揭示了技術模式選擇、應用場景、組件配置和最終用戶期望如何影響產品策略和商業化。

市場區隔提供的洞察揭示了創新和商業性重點的集中領域，以及產品策略如何與最終用戶期望相契合。從技術角度來看，開發人員優先考慮基於雷達的系統和熱成像技術，同時也不斷改進映像基礎的方法。在基於雷達的系統中，連續波雷達、調頻連續波雷達和超寬頻雷達在滲透性、解析度和抗干擾能力方面各有優劣，解決方案設計人員會根據特定應用場景選擇合適的模式。熱成像系統分為長波紅外線和短波紅外線技術，每個波段對環境條件和臨床目標的敏感度各不相同。映像基礎的系統包括熱成像攝影機和RGB攝影機。這些成像模式與先進影像處理演算法的結合，正在拓展基於攝影機的檢測技術的應用範圍，使其不再局限於受控環境。

區域策略指南：說明不同的管理體制、製造優勢和醫療保健服務模式如何影響非接觸式生命徵象檢測系統的採用和商業化決策

區域趨勢對於確定非接觸式生命徵象檢測系統的技術採納路徑、採購決策和監管協調至關重要。在美洲，由綜合醫療網路、私人支付方、Start-Ups和成熟的醫療設備製造商組成的強大生態系統，為醫療技術的採納提供了強力的支持。這種環境雖然有利於快速進行試點計畫並與臨床系統建立合作關係，但也對供應商提出了嚴格的報銷要求和合規性預期，從而影響產品規格和證據產生策略。

評估組件創新者相對於平台提供者的競爭角色：重點關注策略聯盟、垂直整合和軟體主導的差異化

非接觸式生命徵象偵測領域的競爭格局由專業組件供應商、系統整合商、軟體平台供應商和研究機構共同構成。提供高性能雷達晶片、熱感測器和相機模組的組件供應商在上游工程，他們掌控著決定設備製造商可用精度和成本的藍圖。系統整合商和原始設備製造商 (OEM) 則致力於建立一個強大的技術棧，平衡感測器融合、嵌入式處理和認證演算法，以滿足各種應用的需求。

非接觸式監測領域市場領導可採取切實可行的策略，以增強韌性、加速臨床應用並建構軟體差異化優勢。

產業領導者應採取切實可行的措施，在短期韌性和長期差異化之間取得平衡。首先，他們應投資於模組化架構，將感測器模組與處理和分析層分開。這樣，在供應鏈發生變化或關稅壓力增加時，即可快速進行替換。這種方法不僅可以降低組件風險，還支援「軟體優先」的商業化模式，並透過分析和臨床支援服務產生收入。

採用嚴謹的混合方法，結合相關人員訪談、技術文獻綜述、專利分析和情境測試，以驗證檢驗並找出證據缺口。

本分析的調查方法結合了結構化的檢驗流程，以確保其穩健性和透明度，並輔以多方面的證據基礎。主要研究包括對工程師、臨床使用者、採購負責人和監管專家的訪談，以收集關於性能要求、整合挑戰和應用促進因素的第一手資料。此外，還對已發表的檢驗研究、白皮書和標準文件進行了技術審查，以補充這些定性見解，從而支持對感測器功能和演算法方法的評估。

摘要強調了技術融合、臨床檢驗和供應鏈韌性是決定非接觸式監測持續商業性成功的關鍵因素

總之，非接觸式生命徵象檢測技術正處於一個轉折點。技術成熟度、臨床需求和地緣政治因素相互交織，既帶來了機遇，也帶來了挑戰。多模態感測和邊緣運算分析技術正在拓展其應用範圍，而日益嚴格的監管和隱私保護要求也提高了臨床檢驗和系統設計的標準。 2025年關稅相關的變化凸顯了供應鏈柔軟性和模組化架構的重要性，促使許多企業重新評估其採購和製造策略，並專注於提升韌性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 非接觸式生命徵象檢測器市場（依技術分類）

  • 聲波感測器
  • 基於雷達的系統
    • 連續波雷達
    • 調頻連續波雷達
    • 超寬頻雷達
  • 熱成像系統
    • 長波紅外線
    • 短波紅外線
  • 映像基礎的系統
    • 紅外線攝影機
    • RGB相機

9. 非接觸式生命徵象檢測器市場（依組件分類）

  • 處理器
    • 數位訊號處理器
    • 現場可程式閘陣列
    • 微控制器
  • 感應器
    • 聲波感測器
    • 相機模組
    • 雷達感測器
    • 熱感應器
  • 軟體
    • 開放原始碼平台
    • 專有平台

第10章 非接觸式生命徵象檢測器市場（依應用領域分類）

  • 汽車安全
  • 家用電子電器
  • 衛生保健
    • 家庭監控
    • 醫院監測
    • 遠端患者監護
  • 軍事/國防

第11章 非接觸式生命徵象檢測器市場（依最終用戶分類）

  • 門診治療中心
  • 家庭用戶
  • 醫院
  • 研究所

第12章 非接觸式生命徵象檢測器市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 非接觸式生命徵象檢測器市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國非接觸式生命徵象檢測器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 美國非接觸式生命徵象檢測器市場

第16章 中國非接觸式生命徵象檢測器市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Baxter International Inc.
  • Dragerwerk AG & Co. KGaA
  • EarlySense Ltd.
  • General Electric Company
  • Honeywell International Inc.
  • Koninklijke Philips NV
  • Neteera Technologies Ltd
  • Nihon Kohden Corporation
  • OMRON HEALTHCARE Co., Ltd.
  • Teledyne Technologies Incorporated
  • Vayyar Imaging Ltd.
  • Xandar Kardian Ltd.
Product Code: MRR-4F7A6D4FF37C

The Non-contact Vital Signs Detector Market was valued at USD 338.80 million in 2025 and is projected to grow to USD 368.83 million in 2026, with a CAGR of 10.17%, reaching USD 667.58 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 338.80 million
Estimated Year [2026] USD 368.83 million
Forecast Year [2032] USD 667.58 million
CAGR (%) 10.17%

An authoritative primer on the technological foundations, stakeholder expectations, and regulatory drivers shaping non-contact vital signs detection across clinical and consumer domains

Non-contact vital signs detection has evolved from a niche research pursuit into a multidimensional technology frontier that intersects healthcare, consumer electronics, automotive safety, and defense. Recent advances in sensor fidelity, signal processing, and machine learning have made it possible to capture heart rate, respiratory rate, and motion-related biomarkers without direct skin contact, creating new modalities for continuous monitoring across clinical and nonclinical settings. As adoption broadens, stakeholders face a complex interplay of clinical validation requirements, regulatory pathways, and privacy considerations that will determine how rapidly these systems move from pilot deployments to routine use in homes, hospitals, and public spaces.

At the same time, the ecosystem supporting non-contact detection is expanding. Integrators combine radar, thermal, acoustic, and video modalities to improve robustness across lighting, movement, and occlusion scenarios, while edge-focused software architectures enable near-real-time analytics that reduce latency and preserve bandwidth. This introductory section frames the strategic context for the subsequent deep dives by outlining the principal technology classes, typical application domains, and the component stacks that enable deployment. It highlights the shifting expectations of end users-from clinicians who require validated performance under diverse physiological conditions to consumers seeking unobtrusive health insights-and underscores why interoperability and data governance are now core commercial requirements.

Looking ahead, the sector's trajectory will hinge on several cross-cutting dynamics: the maturation of regulatory frameworks for algorithmic medical devices, the ability of suppliers to secure resilient component sources, and the willingness of purchasers to integrate non-contact outputs into clinical workflows. This introduction positions those dynamics as the anchors of the report's analysis and sets the stage for understanding the transformative shifts, tariff impacts, segmentation insights, and regional considerations that follow.

How modality convergence, edge AI maturation, and regulatory clarity are reshaping product roadmaps and clinical adoption pathways for non-contact health monitoring

The landscape for non-contact vital signs detection is undergoing transformative shifts driven by technological convergence, regulatory evolution, and changing user expectations. Core sensor technologies-radar, thermal imaging, acoustic sensing, and video analytics-are no longer siloed; developers routinely fuse modalities to mitigate individual limitations and to deliver higher-fidelity outputs in real-world environments. Concurrently, edge computing and optimized digital signal processing allow for lower-latency inference and reduced dependency on cloud connectivity, which enhances privacy protections and supports deployment in bandwidth-constrained contexts.

Artificial intelligence models have transitioned from proof-of-concept prototypes to clinically oriented architectures that emphasize interpretability, robustness, and explainability. This shift reflects a growing demand from clinicians and procurement teams for algorithms that can justify decisions and integrate into electronic health records. Moreover, the push for regulatory clarity is encouraging manufacturers to adopt documentation and validation practices consistent with medical device pathways, accelerating the translation of experimental systems into cleared or certified products. As adoption accelerates, interoperability standards and data governance frameworks are emerging as critical enablers for multi-vendor ecosystems, shifting competition from isolated feature advances to platform-level compatibility and secure data exchange.

Finally, market momentum is being shaped by end-user preferences. Patients and caregivers increasingly favor unobtrusive monitoring solutions that preserve dignity and convenience, while healthcare systems prioritize tools that reduce staff burden and enable earlier intervention. Together, these forces are rapidly redefining product roadmaps, procurement criteria, and partnership strategies, creating a landscape where agility in technology integration and clarity in clinical value propositions determine commercial success.

Assessing how 2025 tariff adjustments are catalyzing supply chain resilience efforts, modular design adoption, and procurement strategies in non-contact vital signs systems

Tariff policies introduced in 2025 have introduced a notable layer of complexity into the global supply chains that underpin non-contact vital signs detection systems. Components such as radar modules, thermal imagers, camera modules, and certain semiconductor classes are often sourced from international suppliers, and changes in import duties can materially alter landed costs, component sourcing strategies, and supplier relationships. In response, manufacturers and integrators have pursued a range of tactical and strategic measures to mitigate exposure, including reshoring key assembly operations, negotiating long-term supply contracts, and qualifying alternative suppliers in different jurisdictions.

These adaptive responses are accompanied by operational trade-offs. Sourcing shifts can reduce tariff risk, but they may introduce higher fixed costs, require capital investment in new manufacturing lines, or necessitate requalification of components for regulatory submissions. Procurement teams have increasingly adopted total-cost-of-ownership frameworks that incorporate tariff scenarios, logistics volatility, and quality assurance demands. Parallel to supplier diversification, companies have accelerated efforts to increase localization of software development and firmware maintenance, thereby reducing reliance on cross-border service arrangements that could be impacted by trade policy changes.

From a strategic perspective, tariffs have reinforced the importance of modular design and supplier-agnostic hardware architectures that enable rapid substitution of sensors or processors without extensive system reengineering. Firms are also investing in deeper inventory planning capabilities and flexible manufacturing to buffer against episodic duty changes. Finally, the policy environment has prompted closer collaboration between commercial leaders and regulatory affairs teams, ensuring that any supply chain modifications do not compromise clinical validations or device compliance. Taken together, these adjustments reflect a sector that is adapting to tariff-driven cost pressures through structural changes that prioritize resilience and compliance over short-term cost minimization.

Targeted segmentation analysis revealing how technology modality choices, application contexts, component stacks, and end-user expectations shape product strategy and commercialization

Insights derived from the market's segmentation reveal where innovation and commercial focus are concentrated and how product strategies are aligning with end-user expectations. When segmentation is viewed through the lens of technology, developers are prioritizing radar-based systems and thermal imaging while continuing to refine acoustic and video-based approaches. Within radar-based systems, continuous wave radar, frequency modulated continuous wave radar, and ultra-wideband radar each offer distinct trade-offs in terms of penetration, resolution, and susceptibility to interference, prompting solution architects to select modalities according to intended use cases. Thermal imaging systems split between long wave infrared and short wave infrared technologies, with each band offering differential sensitivity to environmental conditions and clinical targets. Video-based systems encompass both infrared cameras and RGB cameras, and the pairing of these imaging modalities with advanced image processing algorithms has broadened the applicability of camera-based detection beyond controlled settings.

From an application standpoint, commercial focus spans automotive safety, consumer electronics, healthcare, and military and defense. Healthcare applications deserve particular attention because they diversify across home monitoring, hospital monitoring, and remote patient monitoring, each setting imposing distinct requirements for accuracy, latency, and integration with care pathways. This variance in deployment context directs product strategies toward either consumer-grade affordability and ease of use or clinical-grade accuracy and regulatory robustness.

Component segmentation-processors, sensors, and software-illuminates where value accrues within the product stack. Processors encompass digital signal processors, field programmable gate arrays, and microcontrollers, all of which influence latency, power consumption, and on-device inference capabilities. Sensor segmentation includes acoustic sensors, camera modules, radar sensors, and thermal sensors, and choices here determine baseline signal quality and environmental tolerance. Software is bifurcated into open source and proprietary platforms; open source frameworks facilitate rapid prototyping and community validation, while proprietary platforms provide differentiated analytics, clinical support tools, and integration capabilities that can underpin commercial defensibility.

Finally, end-user segmentation across ambulatory care centers, home users, hospitals, and research institutions reflects divergent procurement cycles and performance expectations. Ambulatory care centers and hospitals emphasize interoperability with clinical workflows and evidence-based performance, research institutions often prioritize experimental flexibility and access to raw data streams, and home users demand user experience and data privacy assurances. Understanding these segmented dynamics enables companies to tailor product roadmaps, certification strategies, and go-to-market approaches to the requirements of each customer cohort.

A regional strategic playbook showing how distinct regulatory regimes, manufacturing strengths, and healthcare delivery models influence adoption and commercialization decisions

Regional dynamics are instrumental in determining technology adoption pathways, procurement decisions, and regulatory alignment for non-contact vital signs detection systems. In the Americas, a strong health technology adoption curve is supported by integrated care networks, private payers, and a robust ecosystem of startups and established medical device companies. This environment favors rapid pilot implementations and partnerships with clinical systems, but it also subjects vendors to rigorous reimbursement and compliance expectations that influence product specifications and evidence generation strategies.

Europe, Middle East & Africa present a heterogeneous mix of regulatory regimes and healthcare delivery models that require nuanced market-entry plans. The European regulatory landscape increasingly emphasizes conformity to harmonized standards and clinical evidence, while Middle Eastern markets may prioritize rapid deployment for telemedicine and defense-related applications. Across EMEA, data protection regulations and cultural expectations around monitoring in public and private spaces shape product features and privacy-by-design approaches.

Asia-Pacific is characterized by a diverse set of market maturities, from highly advanced technology clusters to rapidly developing healthcare infrastructures. Several countries in the region have strong manufacturing bases for sensors and electronic components, which can lower production costs and shorten supply chains. This manufacturing proximity also fosters iterative hardware innovation and strategic partnerships. However, regional regulatory variability and competing national standards require deliberate localization strategies for clinical validation and after-sales support. Collectively, these regional distinctions guide where companies prioritize investments in clinical trials, manufacturing capacity, distribution partnerships, and local regulatory expertise.

An assessment of competitive roles from component innovators to platform providers highlighting strategic partnerships, vertical integration, and software-driven differentiation

Competitive dynamics in non-contact vital signs detection are shaped by a mix of specialized component suppliers, systems integrators, software platform providers, and research-focused institutions. Component suppliers that deliver high-performance radar chips, thermal sensors, and camera modules occupy a critical upstream role, as their roadmaps determine the fidelity and cost base available to device manufacturers. Systems integrators and original equipment manufacturers focus on assembling resilient stacks that balance sensor fusion, embedded processing, and certified algorithms to meet the needs of different applications.

Software platform providers play a pivotal role by offering analytics, device management, and clinical decision support layers that can either be packaged with hardware or licensed independently. The choice between open and proprietary software models is central to commercial differentiation; some firms emphasize rapid adoption through open frameworks and developer ecosystems, while others anchor enterprises on proprietary suites that promise validated clinical workflows and enterprise-grade support. Research institutions and specialized labs continue to push the envelope on algorithmic performance, and their collaborations with industry partners frequently lead to early-stage intellectual property and pilot deployments that drive longer-term commercial roadmaps.

Across this constellation of players, strategic alliances and co-development agreements have become more common, as companies seek to combine domain expertise in sensing, clinical validation, and regulatory affairs. This collaboration model reduces time to market for complex solutions and spreads the burden of evidence generation across partners. As a result, winning strategies increasingly emphasize vertical integration where it creates distinct value, complemented by selective partnerships to fill capability gaps and accelerate market entry.

Practical strategic moves for market leaders to enhance resilience, accelerate clinical adoption, and build software-enabled differentiation in non-contact monitoring

Industry leaders should pursue a set of actionable moves that balance near-term resilience with long-term differentiation. First, invest in modular architectures that decouple sensor modules from processing and analytics layers, enabling rapid substitution when supply chain or tariff pressures shift. This approach not only mitigates component risk but also supports a software-first commercialization model that can deliver ongoing revenue through analytics and clinical support services.

Second, prioritize clinical validation pathways early in product development to reduce time-to-adoption in regulated healthcare environments. Early investment in prospective studies, real-world evidence collection, and transparent algorithmic validation builds credibility with clinicians and procurement teams and accelerates reimbursement conversations. In parallel, embed privacy-by-design principles and interoperable data standards to address institutional and consumer concerns about data governance, thereby lowering barriers to integration with electronic health records and enterprise monitoring platforms.

Third, adopt a diversified supplier strategy that blends regional manufacturing capacity with qualified alternative vendors to absorb tariff and logistical shocks. Complement this with inventory and production flexibility that allows for scaling according to demand while preserving quality controls necessary for clinical use. Finally, cultivate partnerships with care providers and research institutions to co-develop use cases and to validate outcomes metrics that matter to payers and clinicians. These collaborations can produce compelling case studies that support commercialization and broaden clinical acceptance. Taken together, these actions provide a roadmap for leaders to navigate operational uncertainty while building defensible, clinically oriented products.

A rigorous mixed-methods approach combining stakeholder interviews, technical literature review, patent analysis, and scenario testing to validate conclusions and identify evidence gaps

The research methodology underpinning this analysis combines a multi-source evidence base with structured validation processes designed to ensure robustness and transparency. Primary research included interviews with engineers, clinical users, procurement officers, and regulatory specialists to capture first-hand perspectives on performance requirements, integration challenges, and adoption drivers. These qualitative insights were complemented by technical reviews of published validation studies, white papers, and standards documents to ground assessments of sensor capabilities and algorithmic approaches.

Secondary research encompassed patent landscaping, supplier roadmaps, and public filings to identify technology trajectories and strategic positioning among component and platform providers. Attention was paid to peer-reviewed literature and conference proceedings to validate claims of clinical performance and to surface emerging evaluation frameworks. The methodology also incorporated scenario analysis to assess the implications of supply chain shocks and policy shifts, enabling a structured view of tactical responses and their operational trade-offs.

Finally, findings were triangulated through stakeholder workshops that reviewed preliminary conclusions and identified potential blind spots. Throughout the process, care was taken to document assumptions, to note areas of evidence scarcity, and to flag topics requiring further primary investigation. This layered approach ensures that the report's conclusions are rooted in a blend of practitioner experience, technical evidence, and strategic foresight.

Concluding synthesis emphasizing the convergence of technology, clinical validation, and supply chain resilience as the determinants of sustained commercial success in non-contact monitoring

In conclusion, non-contact vital signs detection is at an inflection point where technological maturity, clinical demand, and geopolitical factors converge to create both opportunity and complexity. Multi-modal sensing and edge-capable analytics have expanded the universe of feasible applications, while regulatory and privacy expectations are elevating the bar for clinical validation and system design. Tariff-related shifts in 2025 have underscored the importance of supply chain flexibility and modular architectures, prompting many organizations to re-evaluate sourcing and manufacturing strategies in favor of resilience.

Segmentation insights indicate that differentiated product strategies-whether focused on radar-intensive clinical deployments, thermal-enabled safety integrations, or software-led consumer experiences-will determine competitive positioning. Regional dynamics further complicate the picture, as distinct regulatory regimes and manufacturing ecosystems require deliberate localization and partnership strategies. Competitive advantage will accrue to organizations that can combine high-quality sensing hardware with validated analytics, strong clinical evidence, and pragmatic commercialization plans tailored to local market conditions.

Ultimately, success in this sector will depend on the ability to translate technological promise into demonstrable clinical value while managing operational risks. Companies that align product development with rigorous validation, execute on flexible supply chain strategies, and engage closely with clinical stakeholders will be best positioned to capture the long-term benefits of non-contact vital signs monitoring across healthcare and adjacent markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-contact Vital Signs Detector Market, by Technology

  • 8.1. Acoustic Sensors
  • 8.2. Radar Based Systems
    • 8.2.1. Continuous Wave Radar
    • 8.2.2. Frequency Modulated Continuous Wave Radar
    • 8.2.3. Ultra Wideband Radar
  • 8.3. Thermal Imaging Systems
    • 8.3.1. Long Wave Infrared
    • 8.3.2. Short Wave Infrared
  • 8.4. Video Based Systems
    • 8.4.1. Infrared Cameras
    • 8.4.2. Rgb Cameras

9. Non-contact Vital Signs Detector Market, by Component

  • 9.1. Processors
    • 9.1.1. Digital Signal Processor
    • 9.1.2. Field Programmable Gate Array
    • 9.1.3. Microcontroller
  • 9.2. Sensors
    • 9.2.1. Acoustic Sensors
    • 9.2.2. Camera Modules
    • 9.2.3. Radar Sensors
    • 9.2.4. Thermal Sensors
  • 9.3. Software
    • 9.3.1. Open Source Platform
    • 9.3.2. Proprietary Platform

10. Non-contact Vital Signs Detector Market, by Application

  • 10.1. Automotive Safety
  • 10.2. Consumer Electronics
  • 10.3. Healthcare
    • 10.3.1. Home Monitoring
    • 10.3.2. Hospital Monitoring
    • 10.3.3. Remote Patient Monitoring
  • 10.4. Military And Defense

11. Non-contact Vital Signs Detector Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Home Users
  • 11.3. Hospitals
  • 11.4. Research Institutions

12. Non-contact Vital Signs Detector Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Non-contact Vital Signs Detector Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Non-contact Vital Signs Detector Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Non-contact Vital Signs Detector Market

16. China Non-contact Vital Signs Detector Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Baxter International Inc.
  • 17.6. Dragerwerk AG & Co. KGaA
  • 17.7. EarlySense Ltd.
  • 17.8. General Electric Company
  • 17.9. Honeywell International Inc.
  • 17.10. Koninklijke Philips N.V.
  • 17.11. Neteera Technologies Ltd
  • 17.12. Nihon Kohden Corporation
  • 17.13. OMRON HEALTHCARE Co., Ltd.
  • 17.14. Teledyne Technologies Incorporated
  • 17.15. Vayyar Imaging Ltd.
  • 17.16. Xandar Kardian Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONTINUOUS WAVE RADAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONTINUOUS WAVE RADAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONTINUOUS WAVE RADAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FREQUENCY MODULATED CONTINUOUS WAVE RADAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FREQUENCY MODULATED CONTINUOUS WAVE RADAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FREQUENCY MODULATED CONTINUOUS WAVE RADAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ULTRA WIDEBAND RADAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ULTRA WIDEBAND RADAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ULTRA WIDEBAND RADAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY LONG WAVE INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY LONG WAVE INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY LONG WAVE INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SHORT WAVE INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SHORT WAVE INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SHORT WAVE INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY INFRARED CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY INFRARED CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY INFRARED CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RGB CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RGB CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RGB CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY DIGITAL SIGNAL PROCESSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY DIGITAL SIGNAL PROCESSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY DIGITAL SIGNAL PROCESSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FIELD PROGRAMMABLE GATE ARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FIELD PROGRAMMABLE GATE ARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FIELD PROGRAMMABLE GATE ARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MICROCONTROLLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MICROCONTROLLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MICROCONTROLLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CAMERA MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CAMERA MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CAMERA MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY OPEN SOURCE PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY OPEN SOURCE PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY OPEN SOURCE PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROPRIETARY PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROPRIETARY PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROPRIETARY PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AUTOMOTIVE SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AUTOMOTIVE SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AUTOMOTIVE SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONSUMER ELECTRONICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONSUMER ELECTRONICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONSUMER ELECTRONICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MILITARY AND DEFENSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MILITARY AND DEFENSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MILITARY AND DEFENSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME USERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME USERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME USERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 231. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 233. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 264. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 266. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 268. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 269. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 270. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 276. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 277. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 279. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 280. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 281. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 282. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 284. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS,